Pefloxacin-induced arthropathy in an adolescent with brain abscess

Scandinavian Journal of Infectious Diseases

Volumn 28, Issue 6, 1996, Pages 641-643

  Chang, Hoyul ^a   Chung, Moon Hyun ^a,b   Kim, Ji Hye ^a   Kim, Jong Ho ^a  

^a Chung Ang University College of Medicine   (South Korea)

^b Hallym University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; MEDRONATE TECHNETIUM TC 99M; METRONIDAZOLE; PEFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADOLESCENT; ARTHROPATHY; ARTICLE; BONE SCINTISCANNING; BRAIN ABSCESS; CASE REPORT; CLINICAL FEATURE; ELBOW; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; JOINT EFFUSION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING;

EID: 0030513434     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365549609037977     Document Type: Article

References (9)

1. Norrby SR. Side-effect of quinolones: comparisons between quinolones and other antibiotics. Eur J Clin Microbiol Infect Dis 10: 378-383, 1991.
2. Schaad UB, Salam MA, Aujard Y. Dagan R, Green SDR, Peltola H, Rubio TT, Smith AL, Adam D. Use of fluoroquinolones in pediatrics: consensus report of an International Society of Chemotherapy commission. Pediatr Infect Dis J 14: 1-9, 1995.
3. Boerema JBJ, Pauwels R, Scheepers J, Cromabach W. Efficacy and safety of pefloxacin in the treatment of patients with complicated urinary tract infections. J Antimicrob Chemother 17 Suppl B: 103-109, 1986.
4. Chevais M, Reinert P, Rondeau MC, Toblem R, Albengres E, Riant P, Tillement JP. Critical risk/benefit analysis of pefloxacin use in children under 15 years - the problem of arthralgias. Int J Clin Pharmacol Ther Toxicol 25: 306-309, 1987.
5. Pertuiset E, Lenoir G, Jehanne M, Douchan F, Guillot M, Menkes CJ. Tolérance articulaire de la péfloxacine et de l'ofloxacine chez les enfants et adolescents atteints de mucoviscidose. Rev Rhumat 56: 735- 740, 1989.
6. Bailey RR, Natale R, Linton AL. Nalidixic acid arthralgia. Can Med Assoc J 107: 604-605, 1972.
7. Stahlmann R, Merker HJ, Hinz N, Chahoud I, Webb J, Heger W, Neubert D. Ofloxacin in juvenile non-human primates and rats. Arthropathia and drug plasma concentrations. Arch Toxicol 64: 193-204, 1990.
8. Schaad UB, Stoupis C, Wedgwood J, Tschaeppeler H, Vock P. Clinical, radiologic and magnetic resonance monitoring for skeletal toxicity in pediatric patients with cystic fibrosis receiving a three-month course of ciprofloxacin. Pediatr Infect Dis J 10: 723-729, 1991.
9. Schaad UB, Sander E, Wedgwood J, Schaffner T. Morphologic studies for skeletal toxicity after prolonged ciprofloxacin therapy in two juvenile cystic fibrosis patients. Pediatr Infect Dis J 11: 1047-1049, 1992.